10.70DKK+4.90%Mkt Cap: 99.32M DKKP/E: —Last update: 2026-05-13
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidime…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B29.16
P/S11.03
EV/EBITDA—
EV/Revenue9.02
EPS (TTM)-1.32
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-3.70%
FCF Margin-40.77%
Operating CF-4.13M DKK
CapEx (TTM)—
Net Debt/EBITDA—
Net Debt-18.06M DKK
Technical
SMA 5010.95 (-2.2%)
SMA 20011.85 (-9.7%)
Beta0.65
S&P 52W Chg24.23%
Avg Vol (30d)704
Avg Vol (10d)429
Technical Indicators
RSI (14)49.6
MACD-0.1676
MACD Signal-0.1927
MACD Hist.+0.0251
BB Upper11.65 DKK
BB Middle10.69 DKK
BB Lower9.718 DKK
BB Width18.11%
ATR (14)0.7088 DKK
Vol Ratio (20d)0.10x
52W Range
6.50039% of range17.40
52W High17.40 DKK
52W Low6.500 DKK
Profitability
Gross Margin74.36%
EBITDA Margin0.00%
Profit Margin-116.77%
Oper. Margin-220.26%
ROE-53.58%
ROA-33.99%
Revenue Growth8.40%
Earnings Growth—
Balance Sheet
Debt/Equity0.24
Current Ratio3.82
Quick Ratio3.50
Book Value/Sh0.3670 DKK
Cash/Share2.400 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.9.28M
Float2.37M
Insiders56.66%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap99.32M DKK
Enterprise Value81.26M DKK
Revenue (TTM)9.01M DKK
Gross Profit6.62M DKK
Net Income (TTM)-10.40M DKK
Revenue/Share0.9700 DKK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7
Last Price10.70 DKK
CountryDK
SectorHealthcare
IndustryMedical Devices
ISIN—